These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Principles of therapy in reactive arthritis]. Braun J, Eggens U, Sieper J. Wien Klin Wochenschr; 1994; 106(9):259-64. PubMed ID: 8023519 [Abstract] [Full Text] [Related]
3. [Mucocutaneous abnormalities in Chlamydia trachomatis-induced reactive arthritis]. Quint KD, van der Helm-van Mil AH, Bergman W, Lavrijsen AP. Ned Tijdschr Geneeskd; 2010; 154():A1614. PubMed ID: 20699017 [Abstract] [Full Text] [Related]
4. Infection and musculoskeletal conditions: Reactive arthritis. Rihl M, Klos A, Köhler L, Kuipers JG. Best Pract Res Clin Rheumatol; 2006 Dec; 20(6):1119-37. PubMed ID: 17127200 [Abstract] [Full Text] [Related]
5. Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis. Meyer A, Chatelus E, Wendling D, Berthelot JM, Dernis E, Houvenagel E, Morel J, Richer O, Schaeverbeke T, Gottenberg JE, Sibilia J, Club Rhumatisme et Inflammation. Arthritis Rheum; 2011 May; 63(5):1274-80. PubMed ID: 21538314 [Abstract] [Full Text] [Related]
6. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Sieper J, Fendler C, Laitko S, Sörensen H, Gripenberg-Lerche C, Hiepe F, Alten R, Keitel W, Groh A, Uksila J, Eggens U, Granfors K, Braun J. Arthritis Rheum; 1999 Jul; 42(7):1386-96. PubMed ID: 10403266 [Abstract] [Full Text] [Related]
14. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital. Suwannalai P, Auethavekiat P, Udomsubpayakul U, Janvitayanujit S. Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328 [Abstract] [Full Text] [Related]
15. Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison. Carter JD, Valeriano J, Vasey FB. J Rheumatol; 2004 Oct; 31(10):1973-80. PubMed ID: 15468362 [Abstract] [Full Text] [Related]
16. Reactive arthritis: clinical aspects and medical management. Carter JD, Hudson AP. Rheum Dis Clin North Am; 2009 Feb; 35(1):21-44. PubMed ID: 19480995 [Abstract] [Full Text] [Related]
17. [Reiter's syndrome. Description of 2 cases with Chlamydia trachomatis infection]. Cantaluppi P, Filippi C, Scanzi G. Minerva Med; 1991 Sep; 82(9):595-8. PubMed ID: 1945011 [Abstract] [Full Text] [Related]
18. [Use of an experimental Chlamydia trachomatis salpingitis model for evaluating the effectiveness of antibiotics and anti-inflammatory agents on fertility]. Verhoest P, Orfila J, Bissac E. J Gynecol Obstet Biol Reprod (Paris); 1997 Sep; 26(3):309-14. PubMed ID: 9265054 [Abstract] [Full Text] [Related]
19. The evolving story of Chlamydia-induced reactive arthritis. Carter JD, Hudson AP. Curr Opin Rheumatol; 2010 Jul; 22(4):424-30. PubMed ID: 20445454 [Abstract] [Full Text] [Related]
20. [The effect of tetracycline therapy on the laboratory indices of chlamydia infection in Reiter's disease (preliminary report)]. Khamraev AA, Pankratova VN, Brodinova NS, Orlova OE, Shubin SV. Revmatologiia (Mosk); 1990 Jul; (1):17-21. PubMed ID: 2377858 [Abstract] [Full Text] [Related] Page: [Next] [New Search]